Carpal Tunnel Syndrome

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
2 programs
6-item Carpal Tunnel Syndrome Symptoms ScaleN/A1 trial
Local Anesthetics LidocaineN/A1 trial
Active Trials
NCT05927896CompletedEst. Oct 2021
NCT04833777CompletedEst. Dec 2022
PAVmed
PAVmedNY - New York
1 program
CarpX DeviceN/A1 trial
Active Trials
NCT03747510CompletedEst. Dec 2019
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Study DeviceN/A1 trial
Active Trials
NCT03498287Completed88Est. Apr 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsLocal Anesthetics Lidocaine
City Therapeutics6-item Carpal Tunnel Syndrome Symptoms Scale
PAVmedCarpX Device
Mission TherapeuticsStudy Device

Clinical Trials (4)

Total enrollment: 88 patients across 4 trials

NCT04833777City TherapeuticsLocal Anesthetics Lidocaine

Does a Different Local Anesthetic Improve Pain After Carpal Tunnel Release?

Start: Jul 2021Est. completion: Dec 2022
N/ACompleted
NCT05927896City Therapeutics6-item Carpal Tunnel Syndrome Symptoms Scale

Reliability and Validity of the Turkish Version of the 6-item Carpal Tunnel Syndrome Symptoms Scale

Start: Apr 2021Est. completion: Oct 2021
N/ACompleted
NCT03747510PAVmedCarpX Device

PAVmed CarpX Device Clinical Study

Start: Jan 2019Est. completion: Dec 2019
N/ACompleted

Non-invasive CTS Device Clinical Trial

Start: Oct 2018Est. completion: Apr 202088 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space